Atcor Medical Inc USA

Atcor Medical Inc USA, doing business as Atcor Medical Holdings LTD of Sidney Australia, manufactures and supplies non-invasive cardiovascular diagnostic devices — specifically the SphygmoCor and SphygmoCor XCEL vascular biometric monitors for pulse wave analysis and central blood pressure measurement — to federal health research and clinical facilities as a prime vendor under full-and-open competition with no small business set-aside designation.

Atcor Medical is a for-profit corporate entity headquartered in Naperville, Illinois, operating as the original equipment manufacturer of the SphygmoCor platform. The vendor holds no SBA certifications and competes exclusively in unrestricted procurements. Primary NAICS categorization centers on Surgical and Medical Instrument Manufacturing (31 of 43 awards), with secondary PSC codes in Medical and Surgical Instruments, Equipment, and Supplies (21 awards) and Laboratory Equipment and Supplies (15 awards). The vendor's federal footprint is narrow in scope but concentrated in a specific market: cardiovascular research infrastructure and clinical diagnostic support at research hospitals and VA medical centers.

Customer concentration runs heavily toward NIH institutes and the Veterans Health Administration. The top five customer organizations by award count and dollar value together account for between 37% and 39% of Atcor's recent award volume. The National Heart Lung and Blood Institute leads with four awards totaling $109 thousand in combined potential value, followed by Veterans Integrated Service Network 2 (three awards, $82 thousand), the National Institute of Diabetes and Digestive and Kidney Diseases (three awards, $74 thousand), and the National Institute on Aging (three awards, $58 thousand). The vendor has served 20 distinct federal agencies over the award period, but engagement is thin — most customer relationships consist of one to three purchase orders for device supply and maintenance.

Recent representative awards include a $28.4 thousand firm fixed-price purchase order from the National Institute of Diabetes and Digestive and Kidney Diseases in September 2025 for a SphygmoCor XCEL system with multiple cuff sizes, a notebook computer, and a maintenance contract; a $28.6 thousand purchase order from Veterans Integrated Service Network 12 in May 2024 for SphygmoCor and SphygmoCor XCEL devices supporting VA clinical research; and a $19.6 thousand purchase order from the National Institute of Diabetes and Digestive and Kidney Diseases in September 2026 for a SphygmoCor XCEL vascular biometric monitor. All awards are purchase orders with no parent IDIQs, BPAs, or GWACs; each transaction is standalone.

Activity is sparse and declining: three awards in 2021, three in 2023, then one award each in 2024, 2025, and 2026. Combined potential value across all forty-three awards is $981 thousand, with one hundred percent of that amount obligated. Only one award carries ultimate completion within the next twenty-four months ($20 thousand potential value). The vendor operates exclusively as a prime and has no subcontractor footprint in the federal space. Atcor Medical's federal position is that of a niche medical equipment supplier to research-grade health agencies with no contracting vehicles, no teaming relationships, and minimal recurring business.